Skip to content
PubMed This is a summary of 66 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 66 referenced papers

Top Authors

Adeline L. Vanderver
Children's Hospital of Philadelphia
Marjo S. van der Knaap
Emma Kinderziekenhuis
Nicole I. Wolf
Emma Kinderziekenhuis
Geneviève Bernard
McGill University Health Centre
Francesco Gavazzi
Children's Hospital of Philadelphia
Laura Ann Adang
Children's Hospital of Philadelphia
Davide Tonduti
University of Milan
Anjana Sevagamoorthy
Children's Hospital of Philadelphia
Asako Takanohashi
Children's Hospital of Philadelphia
Brittany A. Charsar
Children's Hospital of Philadelphia

Top Institutions

Ranked by publications Top 10 institutions

References

References (66)
  1. 1

    Percutaneous endoscopic gastrostomy versus nasogastric tube feeding for adults with swallowing disturbances.

    Gomes CA, Andriolo RB, Bennett C, et al.

    The Cochrane database of systematic reviews 2015; CD008096 doi:10.1002/14651858.CD008096.pub4.

    PMID: 25997528
  2. 2

    Myelin-associated glycoprotein gene mutation causes Pelizaeus-Merzbacher disease-like disorder.

    Lossos A, Elazar N, Lerer I, et al.

    Brain : a journal of neurology 2015; (138(Pt 9)):2521-36 doi:10.1093/brain/awv204.

    PMID: 26179919
  3. 3

    Hypomyelinating disorders: An MRI approach.

    Barkovich AJ, Deon S

    Neurobiology of disease 2016; (87()):50-8.

    PMID: 26477299
  4. 4

    Play-based procedural preparation and support intervention for cranial radiation.

    Grissom S, Boles J, Bailey K, et al.

    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2016; (24(6)):2421-7 doi:10.1007/s00520-015-3040-y.

    PMID: 26634562
  5. 5

    TUBB4A-related hypomyelinating leukodystrophy: New insights from a series of 12 patients.

    Tonduti D, Aiello C, Renaldo F, et al.

    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2016; (20(2)):323-330 doi:10.1016/j.ejpn.2015.11.006.

    PMID: 26643067
  6. 6

    Diffuse hypomyelination is not obligate for POLR3-related disorders.

    La Piana R, Cayami FK, Tran LT, et al.

    Neurology 2016; (86(17)):1622-6 doi:10.1212/WNL.0000000000002612.

    PMID: 27029625
  7. 7

    [A report of atypical hypomyelinating leukodystrophy with atrophy of the basal ganglia and cerebellum caused by a de novo mutation in tubulin beta 4A (TUBB4A) gene and literature review].

    Du Y, Li C, Guo J, et al.

    Zhonghua nei ke za zhi 2017; (56(6)):433-437 doi:10.3760/cma.j.issn.0578-1426.2017.06.009.

    PMID: 28592043
  8. 8

    TUBB4A mutations result in specific neuronal and oligodendrocytic defects that closely match clinically distinct phenotypes.

    Curiel J, Rodríguez Bey G, Takanohashi A, et al.

    Human molecular genetics 2017; (26(22)):4506-4518 doi:10.1093/hmg/ddx338.

    PMID: 28973395
  9. 9

    Pharmacological and neurosurgical interventions for managing dystonia in cerebral palsy: a systematic review.

    Fehlings D, Brown L, Harvey A, et al.

    Developmental medicine and child neurology 2018; (60(4)):356-366 doi:10.1111/dmcn.13652.

    PMID: 29405267
  10. 10

    Standard Polymeric Formula Tube Feeding in Neurologically Impaired Children: A Five-Year Retrospective Study.

    Dipasquale V, Catena MA, Cardile S, Romano C

    Nutrients 2018; (10(6)) doi:10.3390/nu10060684.

    PMID: 29843419
  11. 11

    Motor protein binding and mitochondrial transport are altered by pathogenic TUBB4A variants.

    Vulinovic F, Krajka V, Hausrat TJ, et al.

    Human mutation 2018; (39(12)):1901-1915 doi:10.1002/humu.23602.

    PMID: 30079973
  12. 12

    A systematic review of interventions to reduce psychological distress in pediatric patients receiving radiation therapy.

    O'Connor M, Halkett GK

    Patient education and counseling 2019; (102(2)):275-283 doi:10.1016/j.pec.2018.09.023.

    PMID: 30318385
  13. 13

    Severe TUBB4A-Related Hypomyelination With Atrophy of the Basal Ganglia and Cerebellum: Novel Neuropathological Findings.

    Joyal KM, Michaud J, van der Knaap MS, et al.

    Journal of neuropathology and experimental neurology 2019; (78(1)):3-9 doi:10.1093/jnen/nly105.

    PMID: 30476126
  14. 14

    An update on clinical, pathological, diagnostic, and therapeutic perspectives of childhood leukodystrophies.

    Ashrafi MR, Amanat M, Garshasbi M, et al.

    Expert review of neurotherapeutics 2020; (20(1)):65-84 doi:10.1080/14737175.2020.1699060.

    PMID: 31829048
  15. 15

    POLR3A variants with striatal involvement and extrapyramidal movement disorder.

    Harting I, Al-Saady M, Krägeloh-Mann I, et al.

    Neurogenetics 2020; (21(2)):121-133 doi:10.1007/s10048-019-00602-4.

    PMID: 31940116
  16. 16

    Geographic and Specialty Access Disparities in US Pediatric Leukodystrophy Diagnosis.

    Grineski S, Morales DX, Collins T, et al.

    The Journal of pediatrics 2020; (220()):193-199 doi:10.1016/j.jpeds.2020.01.063.

    PMID: 32143930
  17. 17

    TUBB4A mutations result in both glial and neuronal degeneration in an H-ABC leukodystrophy mouse model.

    Sase S, Almad AA, Boecker CA, et al.

    eLife 2020; (9()).

    PMID: 32463361
  18. 18

    Auditory impairment in H-ABC tubulinopathy.

    Lopez-Juarez A, Gonzalez-Vega A, Kleinert-Altamirano A, et al.

    The Journal of comparative neurology 2021; (529(5)):957-968 doi:10.1002/cne.24990.

    PMID: 32681585
  19. 19

    Impact of Interdisciplinary Team Care for Children With 22q11.2 Deletion Syndrome.

    Hickey SE, Kellogg B, O'Brien M, et al.

    The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association 2020; (57(12)):1362-1369 doi:10.1177/1055665620947985.

    PMID: 32787583
  20. 20

    T2-Pseudonormalization and Microstructural Characterization in Advanced Stages of Late-infantile Metachromatic Leukodystrophy.

    Martin P, Hagberg GE, Schultz T, et al.

    Clinical neuroradiology 2021; (31(4)):969-980 doi:10.1007/s00062-020-00975-2.

    PMID: 33226437
  21. 21

    Hypomyelinating leukodystrophies - unravelling myelin biology.

    Wolf NI, Ffrench-Constant C, van der Knaap MS

    Nature reviews. Neurology 2021; (17(2)):88-103 doi:10.1038/s41582-020-00432-1.

    PMID: 33324001
  22. 22

    Genetic analysis of 20 patients with hypomyelinating leukodystrophy by trio-based whole-exome sequencing.

    Yan H, Ji H, Kubisiak T, et al.

    Journal of human genetics 2021; (66(8)):761-768 doi:10.1038/s10038-020-00896-5.

    PMID: 33597727
  23. 23

    Intrathecal baclofen, selective dorsal rhizotomy, and extracorporeal shockwave therapy for the treatment of spasticity in cerebral palsy: a systematic review.

    Kudva A, Abraham ME, Gold J, et al.

    Neurosurgical review 2021; (44(6)):3209-3228 doi:10.1007/s10143-021-01550-0.

    PMID: 33871733
  24. 24

    Epidemiological, clinical, and genetic characteristics of paediatric genetic white matter disorders in Northern Finland.

    Knuutinen OA, Oikarainen JH, Suo-Palosaari MH, et al.

    Developmental medicine and child neurology 2021; (63(9)):1066-1074 doi:10.1111/dmcn.14884.

    PMID: 33948933
  25. 25

    An Integrated Care Strategy for Pre-schoolers with Suspected Developmental Disorders: The Optimus Co-design Project that has Made it to Regular Care.

    Sarkadi A, Dahlberg A, Leander K, et al.

    International journal of integrated care 2021; (21(2)):3 doi:10.5334/ijic.5494.

    PMID: 33953649
  26. 26

    Longitudinal Evaluation of Cerebellar Signs of H-ABC Tubulinopathy in a Patient and in the taiep Model.

    Alata M, González-Vega A, Piazza V, et al.

    Frontiers in neurology 2021; (12()):702039 doi:10.3389/fneur.2021.702039.

    PMID: 34335454
  27. 27

    Acquisition of Developmental Milestones in Hypomyelination With Atrophy of the Basal Ganglia and Cerebellum and Other TUBB4A-Related Leukoencephalopathy.

    Gavazzi F, Charsar BA, Williams C, et al.

    Journal of child neurology 2021; (36(10)):805-811 doi:10.1177/08830738211000977.

    PMID: 34514881
  28. 28

    In-silico phenotype prediction by normal mode variant analysis in TUBB4A-related disease.

    Fellner A, Goldberg Y, Lev D, et al.

    Scientific reports 2022; (12(1)):58 doi:10.1038/s41598-021-04337-x.

    PMID: 34997144
  29. 29

    H-ABC- and dystonia-causing TUBB4A mutations show distinct pathogenic effects.

    Krajka V, Vulinovic F, Genova M, et al.

    Science advances 2022; (8(10)):eabj9229 doi:10.1126/sciadv.abj9229.

    PMID: 35275727
  30. 30

    A TUBB4A Met363Thr variant in pediatric hypomyelination without atrophy of the basal ganglia.

    Hashiguchi M, Monden Y, Nozaki Y, et al.

    Human genome variation 2022; (9(1)):19 doi:10.1038/s41439-022-00198-6.

    PMID: 35661708
  31. 31

    Functional Investigation of TUBB4A Variants Associated with Different Clinical Phenotypes.

    Xiao H, He H, Wu T, et al.

    Molecular neurobiology 2022; (59(8)):5056-5069 doi:10.1007/s12035-022-02900-9.

    PMID: 35668344
  32. 32

    DYT-TUBB4A (DYT4 Dystonia): Clinical Anthology of 11 Cases and Systematized Review.

    Bally JF, Kern DS, Fearon C, et al.

    Movement disorders clinical practice 2022; (9(5)):659-675 doi:10.1002/mdc3.13452.

    PMID: 35844288
  33. 33

    Experiences of medical traumatic stress in parents of children with medical complexity.

    Dewan T, Birnie K, Drury J, et al.

    Child: care, health and development 2023; (49(2)):292-303 doi:10.1111/cch.13042.

    PMID: 35947493
  34. 34

    A trained communication partner's use of responsive strategies in aided communication with three adults with Rett syndrome: A case report.

    Wandin H, Lindberg P, Sonnander K

    Frontiers in psychology 2022; (13()):989319 doi:10.3389/fpsyg.2022.989319.

    PMID: 36248576
  35. 35

    Gut dysmotility in children with neurological impairment: the nutritional management.

    Corsello A, Scatigno L, Govoni A, et al.

    Frontiers in neurology 2023; (14()):1200101 doi:10.3389/fneur.2023.1200101.

    PMID: 37213895
  36. 36

    The Experience of Parents of Children With Genetically Determined Leukoencephalopathies With the Health Care System: A Qualitative Study.

    Yazdani PA, St-Jean ML, Matovic S, et al.

    Journal of child neurology 2023; (38(5)):329-335 doi:10.1177/08830738231176672.

    PMID: 37225698
  37. 37

    Utility of genetic testing in children with leukodystrophy.

    Zerem A, Libzon S, Ben Sira L, et al.

    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2023; (45()):29-35 doi:10.1016/j.ejpn.2023.05.008.

    PMID: 37267771
  38. 38

    Deep brain stimulation in an adolescent with hypomyelination with atrophy of the basal ganglia and cerebellum due to a TUBB4A mutation: illustrative case.

    MacLean JA, Nataraj J, Olaya J, et al.

    Journal of neurosurgery. Case lessons 2023; (6(2)).

    PMID: 37458337
  39. 39

    Gross Motor Function in Pediatric Onset TUBB4A-Related Leukodystrophy: GMFM-88 Performance and Validation of GMFC-MLD in TUBB4A.

    Gavazzi F, Patel V, Charsar B, et al.

    Journal of child neurology 2023; (38(8-9)):498-504 doi:10.1177/08830738231188159.

    PMID: 37461315
  40. 40

    Mutation in the β-tubulin gene TUBB4A results in epileptic encephalopathy associated with hypomyelinated leucodystrophy: Unexpected findings reveal genetic mosaicism.

    Ben Jdila M, Kammoun F, Abdelmaksoud-Dammak R, et al.

    International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 2023; (83(6)):532-545 doi:10.1002/jdn.10284.

    PMID: 37529938
  41. 41

    Calcification of the pump pouch in patients receiving ITB therapy: A rare complication affecting refill procedure - Analysis of two cases.

    Pavanello M, Ronchetti A, Barretta I, et al.

    Clinical neurology and neurosurgery 2023; (233()):107949 doi:10.1016/j.clineuro.2023.107949.

    PMID: 37703618
  42. 42

    Update on leukodystrophies and developing trials.

    Ceravolo G, Zhelcheska K, Squadrito V, et al.

    Journal of neurology 2024; (271(1)):593-605 doi:10.1007/s00415-023-11996-5.

    PMID: 37755460
  43. 43

    Expanding the phenotypic and genotypic spectrum of DYT-TUBB4A with seven patients from India.

    Garg D, Holla VV, Ganguly J, et al.

    Parkinsonism & related disorders 2024; (124()):107012 doi:10.1016/j.parkreldis.2024.107012.

    PMID: 38762926
  44. 44

    Perioperative Management in Neuromuscular Diseases: A Narrative Review.

    Bhat A, Dean J, Aboussouan LS

    Journal of clinical medicine 2024; (13(10)) doi:10.3390/jcm13102963.

    PMID: 38792504
  45. 45

    Spina bifida transition care in India: strengths amidst challenges.

    Udayakumaran S, Manda VV, Kedia S, et al.

    Neurosurgical focus 2024; (57(2)):E5 doi:10.3171/2024.6.FOCUS24266.

    PMID: 39088854
  46. 46

    Developmental Delay, Hypomyelination, and Nystagmus: Case and Approach.

    Ramanzini LG, Frare JM, Lopes TF, Fighera MR

    Neuro-ophthalmology (Aeolus Press) 2024; (48(5)):369-372 doi:10.1080/01658107.2024.2329120.

    PMID: 39145320
  47. 47

    An Algorithmic Approach to MR Imaging of Hypomyelinating Leukodystrophies.

    Sharma S, Sundaram S, Kesavadas C, Thomas B

    Journal of magnetic resonance imaging : JMRI 2025; (61(4)):1531-1551 doi:10.1002/jmri.29558.

    PMID: 39165110
  48. 48

    Overview of Neuro-Ophthalmic Findings in Leukodystrophies.

    Bettinger CM, Dulz S, Atiskova Y, et al.

    Journal of clinical medicine 2024; (13(17)) doi:10.3390/jcm13175114.

    PMID: 39274327
  49. 49

    Approaches to diagnosis for individuals with a suspected inherited white matter disorder.

    Helman G, Orthmann-Murphy JL, Vanderver A

    Handbook of clinical neurology 2024; (204()):21-35 doi:10.1016/B978-0-323-99209-1.00009-0.

    PMID: 39322380
  50. 50

    Rare forms of hypomyelination and delayed myelination.

    Mura E, Parazzini C, Tonduti D

    Handbook of clinical neurology 2024; (204()):225-252 doi:10.1016/B978-0-323-99209-1.00002-8.

    PMID: 39322381
  51. 51

    MRI pattern recognition in white matter disease.

    Wolf NI, Engelen M, van der Knaap MS

    Handbook of clinical neurology 2024; (204()):37-50 doi:10.1016/B978-0-323-99209-1.00019-3.

    PMID: 39322391
  52. 52

    The natural history of variable subtypes in pediatric-onset TUBB4A-related leukodystrophy.

    Gavazzi F, Charsar B, Hamilton E, et al.

    Molecular genetics and metabolism 2025; (144(3)):109048 doi:10.1016/j.ymgme.2025.109048.

    PMID: 39951964
  53. 53

    POLR3-Related Leukodystrophy: A Qualitative Study on Parents' Experiences With the Health Care System.

    Le A, Thibault KA, Yazdani PA, et al.

    Pediatric neurology 2025; (166()):81-87 doi:10.1016/j.pediatrneurol.2025.02.011.

    PMID: 40106878
  54. 54

    Magnetic resonance imaging and spectroscopy in hypomyelinating leukodystrophy.

    Takanashi JI

    Brain & development 2025; (47(3)):104345 doi:10.1016/j.braindev.2025.104345.

    PMID: 40174481
  55. 55

    Between Anxiety and Adaptation: Children's and Parents' Experiences with Botulinum Toxin Treatment in Cerebral Palsy.

    Sæther R, Brændvik SM, Elvrum AG

    Journal of clinical medicine 2025; (14(9)) doi:10.3390/jcm14093164.

    PMID: 40364195
  56. 56

    Perspectives: Mental health challenges and medical trauma: focus on cystinosis patients and caregivers.

    Doyle MH, Meschke C

    Frontiers in pediatrics 2025; (13()):1592513 doi:10.3389/fped.2025.1592513.

    PMID: 40510681
  57. 57

    Prescribing Assistive Technology: Focus on Children With Complex Communication Needs: Clinical Report.

    Desch LW, Hobart-Porter LJ, Houtrow A,

    Pediatrics 2025; (156(1)) doi:10.1542/peds.2025-072216.

    PMID: 40518139
  58. 58

    [Expert consensus on the diagnosis and treatment of sleep-disordered breathing related to neuromuscular diseases].

    Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases 2025; (48(9)):815-830 doi:10.3760/cma.j.cn112147-20250614-00332.

    PMID: 40925732
  59. 59

    Posttraumatic Stress in Parents of Hospitalized Children With Medical Complexity.

    Dewan T, Whiteley A, Birnie K, et al.

    Hospital pediatrics 2025; (15(11)):921-931 doi:10.1542/hpeds.2025-008390.

    PMID: 41038625
  60. 60

    Critical Functional Domains in Pediatric Onset TUBB4A-Related Leukodystrophy: A Clinical and Caregiver's Perspective.

    Gavazzi F, Patel V, Erler JA, et al.

    Pediatric neurology 2025; (173()):156-165 doi:10.1016/j.pediatrneurol.2025.09.019.

    PMID: 41129987
  61. 61

    Impact of HLD6-associated TUBB4A mutant proteins on cell morphogenesis.

    Kasamatsu Y, Tanaka M, Minegishi M, et al.

    BMC research notes 2025; (18(1)):449 doi:10.1186/s13104-025-07537-0.

    PMID: 41146320
  62. 62

    The Impact of RNA Polymerase III-Related Leukodystrophy on Nonaffected Family Members: A Qualitative Study.

    Le A, Thibault KA, Yazdani PA, et al.

    Pediatric neurology 2026; (176()):31-40 doi:10.1016/j.pediatrneurol.2025.12.004.

    PMID: 41518854
  63. 63

    Therapeutic suppression of Tubb4a rescues H-ABC leukodystrophy.

    Sase S, Hacker JL, Napit PR, et al.

    Molecular therapy : the journal of the American Society of Gene Therapy 2026; (34(5)):2923-2943 doi:10.1016/j.ymthe.2026.01.016.

    PMID: 41566774
  64. 64

    Rigorous genetic diagnosis review in natural history studies.

    Pizzino A, Arnold K, Wiener E, et al.

    Orphanet journal of rare diseases 2026; (21(1)).

    PMID: 42050713
  65. 65

    Normative modeling for quantitative brain MRI phenotyping and biomarker discovery for pediatric leukodystrophies.

    Karandikar S, Sevagamoorthy A, Zimmerman D, et al.

    medRxiv : the preprint server for health sciences 2026; doi:10.64898/2026.05.22.26353512.

    PMID: 42245025
  66. 66

    Generation of three induced pluripotent stem cell lines from individuals with late infantile TUBB4A-associated leukodystrophy caused by a c.1172G > A (p.R391H) de novo mutation in TUBB4A.

    Hou Z, Gagne A, Cai J, et al.

    Stem cell research 2026; (95()):104063 doi:10.1016/j.scr.2026.104063.

    PMID: 42501571